Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors July 8, 2022 No Comments
Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine June 22, 2022 No Comments
Scientists discover new mechanism that causes cardiac hypertrophy in response to pressure overload June 15, 2022 No Comments
CiPA used to validate Axol's iPSC-derived ventricular cardiomyocytes for cardiac safety testing June 8, 2022 No Comments